Key result
Mechanical thrombectomy achieves ~92% successful reperfusion in cardiac myxoma patients with acute ischemic stroke.
Why the study?
The role of mechanical thrombectomy in acute ischemic stroke patients with cardiac myxoma remains unclear, and no guidelines exist for this population.
Is mechanical thrombectomy safe and effective for achieving reperfusion and improving functional outcomes in patients with acute ischemic stroke caused by cardiac myxoma?
Systematic Review (n=46)
Yes
Is mechanical thrombectomy safe and effective for achieving reperfusion and improving functional outcomes in patients with acute ischemic stroke caused by cardiac myxoma?
Mechanical thrombectomy appears to be a safe and highly effective reperfusion strategy for acute ischemic stroke secondary to cardiac myxoma, achieving high recanalization rates and favorable functional outcomes.
Answers are grounded in this paper and cite their sources.
Supports MT consideration in myxoma-related AIS; leaves open need for prospective validation.
Background and Purpose: Acute ischemic stroke (AIS) is a common and life-threatening complication of patients with cardiac myxoma (CM). The role of the mechanical thrombectomy (MT) technique in CM-AIS patients remains unclear, and no guidelines exist for this population. Therefore, we conducted a case series study of MT in CM-AIS patients to investigate its safety and efficacy via a pooled analysis of published literature. Methods: Eleven CM-AIS patients who underwent MT between 2016 and 2021 were screened from multicenter stroke databases. Clinical, procedural, and outcome data were obtained from medical records. A systematic review was conducted to identify additional cases from published studies by searching PubMed and China National Knowledge Infrastructure databases. We then performed a pooled analysis of the published cases. Results: In the case series study, most patients were male (81.8%), with a median age of 51 years. All patients had CM located in the left atrium. The rate of successful reperfusion using the first-line thrombectomy technique was 100% with stent retriever (SR) and 66.7% with direct aspiration (DA), which resulted in overall successful reperfusion in 94.1% of all occlusions. The retrieved emboli of the five patients who underwent histopathology examination were identified as myxoma components. Hemorrhagic transformation was observed in five (45.5%) patients, of whom one was symptomatic (9.1%). Three-month favorable functional outcomes were achieved in five (45.5%) patients with a 3-month mortality rate of 18.2%. For the literature review, 35 cases with 51 target vessel occlusions were identified and included in the pooled analysis. The rate of successful reperfusion following first-line thrombectomy did not differ between SR (30 patients, 90.9%) and DA (10 patients, 83.3%). The overall successful reperfusion rate was 91.8% of all occlusions. Three-month favorable functional outcomes were achieved in 21 (60.0%) patients, and the mortality rate was 8.6%. Conclusions: Our findings suggest that MT is not only an effective technique but also a safe option for CM-AIS patients with large vessel occlusion. MT has several advantages for this population, which include a high recanalization rate, low bleeding risk, and the ability to evaluate the source of emboli and the etiology of stroke.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2022) conducted a systematic review in Acute ischemic stroke with cardiac myxoma (n=46). Mechanical thrombectomy was evaluated on Overall successful reperfusion. Mechanical thrombectomy for acute ischemic stroke in patients with cardiac myxoma achieved an overall successful reperfusion rate of 91.8% and a 60.0% rate of 3-month favorable functional outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: